Ruby Gadelrab and Jill Hagenkord have worked in the health-tech industry and have ideas of how to keep it from making serious mistakes. They’re working to help the next generation of health-tech entrepreneurs and the investors who back them. That involves a new brand of “medical diligence,” they say.
Trending:
These health-tech veterans want to avert the next Theranos disaster with 'medical diligence'